Clinical trial
Alpha to Beta Cell Communication in Health and Disease
NCT07224334 is registered in ClinicalTrials.gov with David D'Alessio, M.D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alpha to Beta Cell Communication in Health and Disease
- Lead sponsor
- David D'Alessio, M.D.
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- December 30, 2025
- Completion date
- December 31, 2027
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes (dm)